Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860

In silico prediction of protein-protein interactions in human macrophages

Souiai, O., Guerfali, F. Z., Miled, S. B., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,785

Significance analysis of microarrays applied to the ionizing radiation response

Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568

Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophy

Miller, J. W., Urbinati, C. R., Teng‐umnuay, P., Stenberg, M. G., Byrne, B. J., Thornton, C. A., & Swanson, M. S. (2000) · The EMBO Journal · doi:10.1093/emboj/19.17.4439 · Cited by 937

Expandable DNA repeats and human disease

Mirkin, S. M. (2007) · Nature · doi:10.1038/nature05977 · Cited by 934

Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy

Savkur, R. S., Philips, A. V., & Cooper, T. A. (2001) · Nature Genetics · doi:10.1038/ng704 · Cited by 795

A Muscleblind Knockout Model for Myotonic Dystrophy

Kanadia, R. N., Johnstone, K. A., Mankodi, A., Lungu, C., Thornton, C. A., Esson, D., Timmers, A. M., Hauswirth, W. W., & Swanson, M. S. (2003) · Science · doi:10.1126/science.1088583 · Cited by 743

Myotonic Dystrophy in Transgenic Mice Expressing an Expanded CUG Repeat

Mankodi, A. K., Logigian, E. L., Callahan, L. M., McClain, C., White, R. J., Henderson, D., Krym, M., & Thornton, C. A. (2000) · Science · doi:10.1126/science.289.5485.1769 · Cited by 738

Expanded CUG Repeats Trigger Aberrant Splicing of ClC-1 Chloride Channel Pre-mRNA and Hyperexcitability of Skeletal Muscle in Myotonic Dystrophy

Mankodi, A. K., Takahashi, M. P., Jiang, H. N., Beck, C. L., Bowers, W. J., Moxley, R. T., Cannon, S. C., & Thornton, C. A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00563-4 · Cited by 672

Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy

Buxton, J. L., Shelbourne, P., Davies, J. L., Jones, C., Tongeren, T. V., Aslanidis, C., de Jong, P., Jansen, G., Anvret, M., Riley, B. P., et al. (1992) · Nature · doi:10.1038/355547a0 · Cited by 623

Age of Onset of RNA Toxicity Influences Phenotypic Severity: Evidence from an Inducible Mouse Model of Myotonic Dystrophy (DM1)

Gladman, J. T., Mandal, M., Srinivasan, V., & Mahadevan, M. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072907 · Cited by 20

Development of an AP-FRET Based Analysis for Characterizing RNA-Protein Interactions in Myotonic Dystrophy (DM1)

Rehman, S., Gladman, J. T., Periasamy, A., Sun, Y., & Mahadevan, M. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095957 · Cited by 20

An engineered RNA binding protein with improved splicing regulation

Hale, M. A., Richardson, J. I., Day, R. C., McConnell, O. L., Arboleda, J. D., Wang, E. T., & Berglund, J. A. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1304 · Cited by 19

Cellular Senescence and Aging in Myotonic Dystrophy

Hasuike, Y., Mochizuki, H., & Nakamori, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042339 · Cited by 22

Molecular characterization of myotonic dystrophy fibroblast cell lines for use in small molecule screening

Jenquin, J. R., O’Brien, A., Poukalov, K., Lu, Y., Frias, J. A., Shorrock, H. K., Richardson, J. I., Mazdiyasni, H., Yang, H., Huigens, R. W., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104198 · Cited by 19

Drosophila muscleblind Codes for Proteins with One and Two Tandem Zinc Finger Motifs

Irion, U. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034248 · Cited by 19

Noncoding RNAs: Emerging Players in Muscular Dystrophies

Falcone, G., Perfetti, A., Cardinali, B., & Martelli, F. (2014) · BioMed Research International · doi:10.1155/2014/503634 · Cited by 22

Correction of Clcn1 alternative splicing reverses muscle fiber type transition in mice with myotonic dystrophy

Hu, N., Kim, E., Antoury, L., & Wheeler, T. M. (2023) · Nature Communications · doi:10.1038/s41467-023-37619-1 · Cited by 19

RNA Helicases in Microsatellite Repeat Expansion Disorders and Neurodegeneration

Castelli, L. M., Benson, B. C., Huang, W.-P., Lin, Y.-H., & Hautbergue, G. M. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.886563 · Cited by 18

Brain tumors in patients with myotonic dystrophy: a population‐based study

Gadalla, S. M., Pfeiffer, R. M., Kristinsson, S. Y., Björkholm, M., Landgren, O., & Greene, M. H. (2015) · European Journal of Neurology · doi:10.1111/ene.12886 · Cited by 18

A fly model for the CCUG-repeat expansion of myotonic dystrophy type 2 reveals a novel interaction with MBNL1

Yu, Z., Goodman, L. D., Shieh, S.-Y., Ma, M., Teng, X., Zhu, Y., & Bonini, N. M. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu507 · Cited by 20

Two Enhancers Control Transcription of Drosophila muscleblind in the Embryonic Somatic Musculature and in the Central Nervous System

Bargiela, A., Llamusí, B., Cerro-Herreros, E., & Artero, R. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093125 · Cited by 18

Alternative Splicing Outcomes Across an RNA-Binding Protein Concentration Gradient

Ellis, J. A., Hale, M. A., Cleary, J. D., Wang, E. T., & Berglund, J. A. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168156 · Cited by 16

Computational challenges, tools, and resources for analyzing co‐ and post‐transcriptional events in high throughput

Bahrami‐Samani, E., Vo, D. T., Araujo, P. R. D., Vogel, C., Smith, A. D., Penalva, L. O. F., & Uren, P. J. (2014) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1274 · Cited by 15

Conservation of context-dependent splicing activity in distant Muscleblind homologs

Oddo, J. C., Saxena, T., McConnell, O. L., Berglund, J. A., & Wang, E. T. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw735 · Cited by 17

Benign and malignant tumors in the UK myotonic dystrophy patient registry

Alsaggaf, R., Wang, Y., Marini‐Bettolo, C., Wood, L., Nikolenko, N., Lochmüller, H., Greene, M. H., & Gadalla, S. M. (2017) · Muscle & Nerve · doi:10.1002/mus.25736 · Cited by 17

Expanded CUG Repeats Trigger Disease Phenotype and Expression Changes through the RNAi Machinery in C. elegans

Qawasmi, L., Braun, M., Guberman, I., Cohen, E., Naddaf, L., Mellul, A., Matilainen, O., Roitenberg, N., Share, D., Stupp, D., et al. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.03.003 · Cited by 17

PolyQ-expanded ataxin-2 aggregation impairs cellular processing-body homeostasis via sequestering the RNA helicase DDX6

Wang, J., Liu, Y., Zhang, X., Liu, Y.-H., Jiang, L., & Hu, H. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107413 · Cited by 16

Experimental and Computational Considerations in the Study of RNA-Binding Protein-RNA Interactions

Nostrand, E. L. V., Huelga, S. C., & Yeo, G. W.-M. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-29073-7_1 · Cited by 17

Faulty RNA splicing: consequences and therapeutic opportunities in brain and muscle disorders

Pagliarini, V., Rosa, P. L., & Sette, C. (2017) · Human Genetics · doi:10.1007/s00439-017-1802-y · Cited by 16

Alteration in gene expression profile of thymomas with or without myasthenia gravis linked with the nuclear factor‐kappaB/autoimmune regulator pathway to myasthenia gravis pathogenesis

Guo, F., Wang, C., Wang, S., Zhang, J., Yan, Y., Guan, Z., & Meng, F. (2019) · Thoracic Cancer · doi:10.1111/1759-7714.12980 · Cited by 16

Hybrid splicing minigene and antisense oligonucleotides as efficient tools to determine functional protein/RNA interactions

Cywoniuk, P., Taylor, K., Sznajder, Ł. J., & Sobczak, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-17816-x · Cited by 17

hnRNP L is essential for myogenic differentiation and modulates myotonic dystrophy pathologies

Alexander, M. S., Hightower, R. M., Reid, A. L., Bennett, A. H., Iyer, L. K., Slonim, D. K., Saha, M., Kawahara, G., Kunkel, L. M., Kopin, A. S., et al. (2021) · Muscle & Nerve · doi:10.1002/mus.27216 · Cited by 16

Staufen from embryo polarity to cellular stress and neurodegeneration

Boccaccio, G. L. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s277 · Cited by 17

Alternative splicing of the neurofibromatosis type 1 pre-mRNA is regulated by the muscleblind-like proteins and the CUG-BP and ELAV-like factors

Barron, V. A., Geng, C., Ladd, A. N., & Lou, H. J. (2012) · BMC Molecular Biology · doi:10.1186/1471-2199-13-35 · Cited by 15

(CCUG)n RNA toxicity in a Drosophila model for myotonic dystrophy type 2 (DM2) activates apoptosis

Yenigun, V. B., Sirito, M., Amcheslavky, A., Czernuszewicz, T. J., Colonques-Bellmunt, J., García-Alcover, I., Wojciechowska, M., Bolduc, C., Chen, Z., López, A., et al. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.026179 · Cited by 15

Transcriptional signatures of synaptic vesicle genes define myotonic dystrophy type I neurodegeneration

Jiménez-Marín, A., Diez, I. P., Labayru, G., Sistiaga, A., Caballero, M. C., Andrés‐Benito, P., Sepulcre, J., Ferrer, I., de Munaín, A. L., & Cortés, J. M. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12725 · Cited by 14

Localization elements and zip codes in the intracellular transport and localization of messenger RNAs in Saccharomyces cerevisiae

Chaudhuri, A., Das, S., & Das, B. (2020) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1591 · Cited by 16

Zebrafish mbnl mutants model physical and molecular phenotypes of myotonic dystrophy

Hinman, M. N., Richardson, J. I., Sockol, R. A., Aronson, E. D., Stednitz, S. J., Murray, K. N., Berglund, J. A., & Guillemin, K. J. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.045773 · Cited by 15

Functions of the Muscleblind-like protein family and their role in disease

Zhou, H., Xu, J., & Pan, L. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02102-5 · Cited by 14

A comprehensive atlas of fetal splicing patterns in the brain of adult myotonic dystrophy type 1 patients

Degener, M. J. F., van Cruchten, R. T. P., Otero, B. A., Wang, E. T., Wansink, D. G., & Hoen, P. A. C. ’. (2022) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqac016 · Cited by 12

MBNL‐dependent impaired development within the neuromuscular system in myotonic dystrophy type 1

Tahraoui‐Bories, J., Mérien, A., González‐Barriga, A., Lainé, J., Leteur, C., Polvèche, H., Carteron, A., de Lamotte, J. D., Nicoleau, C., Polentes, J., et al. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12876 · Cited by 14

Pluripotent Stem Cell-Based Drug Screening Reveals Cardiac Glycosides as Modulators of Myotonic Dystrophy Type 1

Maury, Y., Poydenot, P., Brinon, B., Lesueur, L., Gide, J., Roquevière, S., Côme, J., Polvèche, H., Auboeuf, D., Denis, J. A., et al. (2018) · iScience · doi:10.1016/j.isci.2018.12.019 · Cited by 14

Dissecting domains necessary for activation and repression of splicing by muscleblind-like protein 1

Edge, C., Gooding, C., & Smith, C. W. J. (2013) · BMC Molecular Biology · doi:10.1186/1471-2199-14-29 · Cited by 15

Lineage-specific splicing regulation of MAPT gene in the primate brain

Recinos, Y., Bao, S., Wang, X., Phillips, B. L., Yeh, Y.-T., Weyn‐Vanhentenryck, S. M., Swanson, M. S., & Zhang, C. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100563 · Cited by 12

MBNL splicing factors regulate the microtranscriptome of skeletal muscles

Piasecka, A., Szcześniak, M. W., Sekrecki, M., Kajdasz, A., Sznajder, Ł. J., Baud, A., & Sobczak, K. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae774 · Cited by 12

Alternative splicing regulation of membrane trafficking genes during myogenesis

Hinkle, E. R., Wiedner, H. J., Torres, E. V., Jackson, M., Black, A. J., Blue, R. E., Harris, S. E., Guzmán, B. B., Gentile, G. M., Lee, E. Y., et al. (2022) · RNA · doi:10.1261/rna.078993.121 · Cited by 12

Integrative Proteogenomics for Differential Expression and Splicing Variation in a DM1 Mouse Model

Solovyeva, E. M., Utzinger, S., Vissières, A., Mitchelmore, J., Ahrné, E., Hermes, E., Poetsch, T., Ronco, M., Bidinosti, M., Merkl, C., et al. (2023) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2023.100683 · Cited by 13

Alternatively spliced MBNL1 isoforms exhibit differential influence on enhancing brown adipogenesis

Hung, C.-S., & Lin, J.-C. (2019) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2019.194437 · Cited by 12

SCN5Asplicing variants and the possibility of predicting heart failure-associated arrhythmia

Gao, G., & Dudley, S. C. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.12.180 · Cited by 12

Expansion of Splice-Switching Therapy with Antisense Oligonucleotides

Takeshima, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052270 · Cited by 11

Deciphering the Complex Molecular Pathogenesis of Myotonic Dystrophy Type 1 through Omics Studies

Espinosa-Espinosa, J., González‐Barriga, A., López, A., & Artero, R. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031441 · Cited by 11

A rapid immunohistochemical test to distinguish congenital myotonic dystrophy from X-linked myotubular myopathy

Sewry, C. A., Quinlivan, R. C. M., Squier, W., Morris, G. E., & Holt, I. (2011) · Neuromuscular Disorders · doi:10.1016/j.nmd.2011.10.002 · Cited by 11

NKX2-5, a modifier of skeletal muscle pathology due to RNA toxicity

Gladman, J. T., Yadava, R. S., Mandal, M., Yu, Q., Kim, Y. K., & Mahadevan, M. S. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu443 · Cited by 11

Mapping of In Vivo RNA-Binding Sites by Ultraviolet (UV)-Cross-Linking Immunoprecipitation (CLIP)Preprint

Darnell, J. C., Mele, A., Hung, K. Y. S., & Darnell, R. B. (2018) · Cold Spring Harbor Protocols · doi:10.1101/pdb.top097931 · Cited by 12

BAMORF: A Novel Computational Method for Predicting the Extracellular Matrix Proteins

Guan, L., Zhang, S., & Xu, H. (2017) · IEEE Access · doi:10.1109/access.2017.2751499 · Cited by 10

Altered drug metabolism and increased susceptibility to fatty liver disease in a mouse model of myotonic dystrophy

Dewald, Z., Adesanya, O. A., Bae, H., Gupta, A. S., Derham, J. M., Chembazhi, U. V., & Kalsotra, A. (2024) · Nature Communications · doi:10.1038/s41467-024-53378-z · Cited by 12

Skeletal muscle disorders as risk factors for type 2 diabetes

Tammineni, E. R., Manno, C. D., Oza, G., & Figueroa, L. (2025) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2025.112466 · Cited by 12

Six Serum miRNAs Fail to Validate as Myotonic Dystrophy Type 1 Biomarkers

Fernández‐Costa, J. M., Llamusí, B., Bargiela, A., Zulaica, M., Álvarez-Abril, M. C., Pérez‐Alonso, M., de Munaín, A. L., López, A., & Artero, R. D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150501 · Cited by 13

Altered levels of the splicing factor muscleblind modifies cerebral cortical function in mouse models of myotonic dystrophy

Chen, G., Carter, R. E., Cleary, J. D., Reid, T. S., Ranum, L. P. W., Swanson, M. S., & Ebner, T. J. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.01.003 · Cited by 11

Sustainable recovery of MBNL activity in autoregulatory feedback loop in myotonic dystrophy

Rogalska, Z., & Sobczak, K. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.10.023 · Cited by 8

Muscleblind-1 interacts with tubulin mRNAs to regulate the microtubule cytoskeleton in C. elegans mechanosensory neurons

Puri, D., Sharma, S., Samaddar, S., Ravivarma, S., Banerjee, S., & Ghosh‐Roy, A. (2023) · PLoS Genetics · doi:10.1371/journal.pgen.1010885 · Cited by 7

Discriminating RNA variants with single-molecule allele-specific FISH

Urbanek-Trzeciak, M. O., & Krzyżosiak, W. J. (2016) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2016.09.003 · Cited by 9

Modeling diseases of noncoding unstable repeat expansions using mutant pluripotent stem cells

Yanovsky‐Dagan, S. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i5.823 · Cited by 10

Nxf1 Natural Variant E610G Is a Semi-dominant Suppressor of IAP-Induced RNA Processing Defects

Concepcion, D., Ross, K. D., Hutt, K. R., Yeo, G. W.-M., & Hamilton, B. A. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005123 · Cited by 9

Transcriptome changes in DM1 patients’ tissues are governed by the RNA interference pathway

Braun, M., Shoshani, S., & Tabach, Y. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.955753 · Cited by 8

Coupling of alternative splicing and alternative polyadenylation

Zhang, X., Liu, F., & Zhou, Y. (2024) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2024211 · Cited by 8

To RNA ‐binding and beyond: Emerging facets of the role of Rbfox proteins in development and disease

Mukherjee, A., & Nongthomba, U. (2023) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1813 · Cited by 7

Repeat expansion diseases: when a good RNA turns bad

Dickson, A., & Wilusz, C. J. (2010) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.18 · Cited by 7

Deregulation of RNA Metabolism in Microsatellite Expansion Diseases

Misra, C., Lin, F., & Kalsotra, A. (2018) · Advances in neurobiology · doi:10.1007/978-3-319-89689-2_8 · Cited by 7

The Muscleblind-like protein MBL-1 regulates microRNA expression in Caenorhabditis elegans through an evolutionarily conserved autoregulatory mechanism

Verbeeren, J., Teixeira, J., & Garcia, S. M. D. A. (2023) · PLoS Genetics · doi:10.1371/journal.pgen.1011109 · Cited by 6

Repeat length as a key determinant for disease severity and antisense oligonucleotide activity in myotonic dystrophy type 1

Boujnouni, N. E., Ripken, L., Willemse, M. P., van der Sanden, B. P. G. H., Neveling, K., Hoischen, A., Brock, R. E., & Wansink, D. G. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101502 · Cited by 5

Use of HSALR female mice as a model for the study of myotonic dystrophy type I

Carrascosa-Sàez, M., Colom-Rodrigo, A., González-Martínez, I., Pérez-Gómez, R., García-Rey, A., Piqueras‐Losilla, D., Ballestar, A., Llamusí, B., Cerro-Herreros, E., & Artero, R. D. (2025) · Lab Animal · doi:10.1038/s41684-025-01506-7 · Cited by 5

Tissue Restricted Splice Junctions Originate Not Only from Tissue-Specific Gene Loci, but Gene Loci with a Broad Pattern of Expression

Hestand, M. S., Zeng, Z., Coleman, S. J., Liu, J., & MacLeod, J. N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144302 · Cited by 5

RNA gain-of-function mechanisms in short tandem repeat diseases

Davenport, M. L., & Swanson, M. S. (2024) · RNA · doi:10.1261/rna.080277.124 · Cited by 5

Identification of variants in MBNL1 in patients with a myotonic dystrophy-like phenotype

Larsen, M., Kreß, W., Schoser, B. G. H., Hehr, U., Müller, C. R., & Rost, S. (2016) · European Journal of Human Genetics · doi:10.1038/ejhg.2016.41 · Cited by 5

Modulatory role of RNA helicases in MBNL-dependent alternative splicing regulation

Taylor, K., Piasecka, A., Kajdasz, A., Brzęk, A., Espinoza, M. P., Bourgeois, C. F., Jankowski, A., Borowiak, M., Raczyńska, K. D., Sznajder, Ł. J., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04927-0 · Cited by 5

Alternative Splicing and CaV ‐Associated Channelopathies

Munyao, W., Rahman, M. M., Sabzanov, S., Chu, E. H., Wang, R., Wang, Z., Yu, Y., & Ruggiu, M. (2025) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.70016 · Cited by 4

Alternative splicing of the Snap23 microexon is regulated by MBNL, QKI, and RBFOX2 in a tissue-specific manner and is altered in striated muscle diseases

Gentile, G. M., Blue, R. E., Goda, G. A., Guzmán, B. B., Szymanski, R. A., Lee, E. Y., Engels, N. M., Hinkle, E. R., Wiedner, H. J., Bishop, A. N., et al. (2025) · RNA Biology · doi:10.1080/15476286.2025.2491160 · Cited by 5

Reversal of molecular pathology by RNA-targeting Cas9 in a myotonic dystrophy mouse modelPreprint

Batra, R., Nelles, D. A., Krach, F., Thomas, J. D., Snjader, L., Blue, S. M., Aigner, S., Swanson, M. S., & Yeo, G. W.-M. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/184408 · Cited by 4

Defined d-hexapeptides bind CUG repeats and rescue phenotypes of myotonic dystrophy myotubes in a Drosophila model of the disease

Rapisarda, A. S., Bargiela, A., Llamusí, B., Pont, I., Estrada‐Tejedor, R., García‐España, E., Artero, R. D., & Pérez‐Alonso, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-98866-0 · Cited by 3

Competition for the conserved branch point sequence influences physiological outcomes in pre-mRNA splicing

de Castro, K. L. P., Abril, J., Liao, K., Hao, H., Donohue, J. P., Russell, W. K., & Fagg, W. S. (2026) · eLife · doi:10.7554/elife.103167.3 · Cited by 3

Expression of Smyd1b_tv1 by Alternative Splicing in Cardiac Muscle is Critical for Sarcomere Organization in Cardiomyocytes and Heart Function

Xu, R., Li, S., Chien, C., Zhong, Y., Xiao, H., Fang, S., & Du, S. (2024) · Molecular and Cellular Biology · doi:10.1080/10985549.2024.2402660 · Cited by 3

Myotonic Dystrophy Protein Kinase: Structure, Function and Its Possible Role in the Pathogenesis of Myotonic Dystrophy Type 1

Jonathan, J., Surez-Snchez, R., Leyva‐García, N., Cisneros, B., & Hernndez-Hernndez, O. (2012) · InTech eBooks · doi:10.5772/37238 · Cited by 3

Myotonic Dystrophy Type 1 (DM1): From the Genetics to Molecular Mechanisms

Jonathan, J., & Cisneros, B. (2012) · InTech eBooks · doi:10.5772/30209 · Cited by 3

Ex-vivo characterization of Drosophila heart functional parameters

Artero, R. D., Selma-Soriano, E., Chakraborty, M., Llamusí, B., & Artero, R. D. (2018) · Protocol Exchange · doi:10.1038/protex.2018.034 · Cited by 3

Myotonic Dystrophies Type 1 and 2

Schoser, B. G. H. (2013) · doi:10.1002/9781118635469.ch30 · Cited by 3

Myotonic dystrophy type 2 (DM2) : Diagnostic methods and molecular pathology

Naukkarinen, A. (2011) · Työväentutkimus Vuosikirja · Cited by 3

Comparative Analysis of Splicing Alterations in Three Muscular Dystrophies

Todorow, V., Hintze, S., Schoser, B. G. H., & Meinke, P. (2025) · Biomedicines · doi:10.3390/biomedicines13030606 · Cited by 2

HSALR Mice Exhibit Co-Expression of Proteostasis Genes Prior to Development of Muscle Weakness

Lazic, D. M., Jovanovic, V. M., Karanović, J., Pavicevic, D. S., & Jovanovic, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110793 · Cited by 2

Two ways to misregulate mRNAs in myotonic dystrophy

Voelker, R. B., & Berglund, J. A. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb0210-141 · Cited by 2

Molecular Mechanisms of Myotonic Dystrophy: RNA-Mediated Pathogenesis and RNA-Binding Proteins

Kino, Y., Satoh, J., & Ishiura, S. (2018) · Springer eBooks · doi:10.1007/978-981-13-0508-5_2 · Cited by 2

Gene Therapy and Gene Editing for Myotonic Dystrophy

Chuah, M., Chai, Y. C., Dastidar, S., & VandenDriessche, T. (2019) · Springer eBooks · doi:10.1007/978-3-030-03095-7_30 · Cited by 2

Muscular Dystrophy

Živković, S., & Clemens, P. R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-398270-4.00011-2 · Cited by 2

TNF Signaling Acts Downstream of MiR-322/-503 in Regulating DM1 Myogenesis

Li, M., Xu, F., Liu, Z., Wang, C., Zhao, Y. F., Zhu, G., & Shen, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.843202 · Cited by 2

Alternative Splice Site Selection

Coelho, M. B., & Smith, C. W. J. (2012) · Wiley eBooks · doi:10.1002/9783527636778.ch8 · Cited by 2

The Splice Index as a prognostic biomarker of strength and function in myotonic dystrophy type 1Preprint

Provenzano, M., Ikegami, K., Bates, K., Gaynor, A., Hartman, J. M., Jones, A. S., Butler, A., Berggren, K. N., Dekdebrun, J. M., Hung, M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.10.602610 · Cited by 2

MBNL proteins in health, disease, and therapeutic applications

Musiała, N., Konieczny, P., Plewka, P., Jasiok, A., & Stępniak-Konieczna, E. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag262 · Cited by 1

Muscleblind-like proteins dimerize by forming disulfide bonds to regulate alternative splicing and pathogenic RNA foci formation

Knudson, L. A., Kosti, A., Hildebrandt, R. P., Jennings, E., Zhou, E. X., Moss, K. R., Shi, L., Nguyen, G. N., Janusz, A., Wang, E. T., et al. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag538 · Cited by 1

El papel de los RNAs no-codificantes en la patogénesis de la distrofia miotónica tipo 1

Murillo-Melo, N. M., Borbolla‐Jiménez, F. V., Hernández‐Hernández, Ó., & Magaña, J. J. (2022) · Investigación en Discapacidad · doi:10.35366/103941 · Cited by 1

Muscular dystrophy

Puwanant, A., Živković, S., & Clemens, P. R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00055-1 · Cited by 1

Cure the Incurable: Update of Treatment in Inherited Neuromuscular Disorders

Yu, C.-H., & Lai, K. (2024) · Acta Neurologica Taiwanica · doi:10.4103/ant.33-4_review · Cited by 1

Myotonic Dystrophy

Thornton, C. A. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381510-1.00068-5 · Cited by 1

Congenital myotonic dystrophy—an RNA-mediated disease across a developmental continuumPreprint

Jagannathan, S., & Bradley, R. K. (2017) · Genes & Development · doi:10.1101/gad.302893.117 · Cited by 1

Rbfox1 and mir-33 regulate pleiotropic roles of JAK/STAT signalling during adult myogenesis in Drosophila melanogasterPreprint

Mukherjee, A., & Nongthomba, U. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.02.626327

Treating Myotonic Dystrophy with artificial RNA endonucleases to specifically degrade toxic RNA expansionsPreprint

Wei, T., Hu, H., Jiang, X., Li, Y., Han, W., Yang, Y., Xiao, X., Mao, M., & Wang, Z. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.10.658795 · Cited by 1

Molecular Genetic Basis of Myotonic Dystrophy

Radvánszky, J., & Kádaši, Ľ. (2013) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0023864

Evaluation des Anästhesierisikos bei Myotonen Dystrophien

Kirzinger, L. (2011) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.13679

Functional Antagonism Between CELF and Mbnl Proteins in the CytoplasmPreprint

Wang, E. T., Ward, A. J., Cherone, J. M., Wang, T. T., Giudice, J., Cooper, T. A., & Burge, C. B. (2014) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/009183

SURVEY AND SUMMARY MBNL proteins and their target RNAs, interaction and splicing regulation

Konieczny, P., Stępniak-Konieczna, E., & Sobczak, K. (2014)

Two ways to misregulate mRNAs in myotonic dystrophy

Voelker, R. B., & Berglund, J. A. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb0210-141 · Cited by 2

Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy

Lin, X., Miller, J. W., Mankodi, A., Kanadia, R. N., Yuan, Y., Moxley, R. T., Swanson, M. S., & Thornton, C. A. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl132 · Cited by 510

Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy

Kanadia, R., Shin, J., Yuan, Y., Beattie, S. G., Wheeler, T. M., Thornton, C. A., & Swanson, M. S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604970103 · Cited by 372

Expanded CUG Repeats Dysregulate RNA Splicing by Altering the Stoichiometry of the Muscleblind 1 Complex

Paul, S., Dansithong, W., Jog, S. P., Holt, I., Mittal, S., Brook, J. D., Morris, G. E., Comai, L., & Reddy, S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.255224 · Cited by 67

Muscleblind-Like 1 Knockout Mice Reveal Novel Splicing Defects in the Myotonic Dystrophy Brain

Suenaga, K., Lee, K., Nakamori, M., Tatsumi, Y., Takahashi, M. P., Fujimura, H., Jinnai, K., Yoshikawa, H., Du, H., Ares, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033218 · Cited by 96